Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease
出版年份 2020 全文链接
标题
Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease
作者
关键词
Nonalcoholic fatty liver disease, Ginsenoside-Rg1, RNA-seq, Atf3, Acox2
出版物
LIFE SCIENCES
Volume 267, Issue -, Pages 118986
出版商
Elsevier BV
发表日期
2020-12-30
DOI
10.1016/j.lfs.2020.118986
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway
- (2019) Jiandi Chen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3
- (2019) Jing Fang et al. HEPATOLOGY
- Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
- (2019) Shiv K Sarin et al. Lancet Gastroenterology & Hepatology
- Protective effects of ginsenoside Rg1 on splenocytes and thymocytes in an aging rat model induced by d -galactose
- (2018) Jiazheng Sun et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches
- (2018) Antonella Borrelli et al. Redox Biology
- Ginsenoside Rg1 protects against non-alcoholic fatty liver disease by ameliorating lipid peroxidation, endoplasmic reticulum stress, and inflammasome activation
- (2018) Yashu Xu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Protective Effects and Target Network Analysis of Ginsenoside Rg1 in Cerebral Ischemia and Reperfusion Injury: A Comprehensive Overview of Experimental Studies
- (2018) Weijie Xie et al. Cells
- Hepataprotective effects of ginsenoside Rg1 – A review
- (2017) Yan Gao et al. JOURNAL OF ETHNOPHARMACOLOGY
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Innate Immunity and Inflammation in NAFLD/NASH
- (2016) Marco Arrese et al. DIGESTIVE DISEASES AND SCIENCES
- The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health
- (2016) Mary Rinella et al. HEPATOLOGY
- The Traditional Medicine and Modern Medicine from Natural Products
- (2016) Haidan Yuan et al. MOLECULES
- ACOX2deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment
- (2016) Sílvia Vilarinho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural Products on Nonalcoholic Fatty Liver Disease
- (2015) Jiao-Ya Xu et al. CURRENT DRUG TARGETS
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats
- (2015) Hai-tao Yu et al. Journal of Zhejiang University-SCIENCE B
- Nonalcoholic fatty liver disease
- (2015) Elizabeth M. Brunt et al. Nature Reviews Disease Primers
- The global burden of liver disease: The major impact of China
- (2014) Fu-Sheng Wang et al. HEPATOLOGY
- Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
- (2013) Howard C. Masuoka et al. Annals of the New York Academy of Sciences
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now